U13GM143856
Cooperative Agreement
Overview
Grant Description
National Idea Symposium of Biomedical Research Excellence - NISBRE - Project Summary
The Congressionally mandated Institutional Development Award (IDEA) Program builds biomedical research capacity in the 23 IDEA eligible states and Puerto Rico, which have historically low levels of NIH funding. Through its various funding mechanisms, the program supports all facets of competitive biomedical research including but not limited to basic, clinical, behavioral, and translational research. In addition, it supports faculty development and infrastructure improvements.
These mechanisms are designed to strengthen an institution's ability to support biomedical research, enhance the competitiveness of investigators in securing nationally research funding, and enable clinical and translational research to meet the needs of medically underserved communities.
There are five main components of the IDEA Program: (I) Centers of Biomedical Research Excellence (COBRE), (II) the IDEA Networks of Biomedical Research Excellence (INBRE), (III) the IDEA Infrastructure for Clinical and Translational Research (IDEA-CTR), (IV) STTR Regional Technology Transfer Accelerator Hubs for IDEA States, and the (V) IDEA Co-Funding. Each is designed to enhance research infrastructure and faculty development in IDEA-eligible states. Each program has common needs and similar challenges.
The current proposal will enhance the success of these programs by providing a unique forum for the exchange of ideas and solutions to common problems, as well as foster collaborations among IDEA institutions. In partnership with the IDEA community, NIGMS IDEA officials, and Louisiana State University serving as the meeting contractor, this renewal application requests support for multi-year conferences in response to NIH support for conferences and scientific meetings (Parent R13/U13) (PA-20-207).
The goal is to organize and convene the next three National Idea Symposium of Biomedical Research Excellence (NISBRE) conferences planned for 2022, 2024, and 2026. These highly impactful biennial symposia provide an important platform to showcase the scientific achievements of the 252 IDEA program-funded centers. In addition, the NISBRE conferences provide unique technical workshops, working groups, and forums to promote best practices across IDEA states that enhance mentoring of junior basic and translational scientists and their career development. It will significantly enhance the collaborative interactions among IDEA community partners, scientists, and positively impact future funding opportunities.
The specific aims are:
Aim 1. Plan and organize a biennial scientific symposium to showcase research and enhance communications among all IDEA programs.
Aim 2. Provide educational workshops to expand technological repertoire and career skills that improve competitiveness. This aim will seek to promote the development of best practices and publish guidelines based on the extensive expertise of IDEA researchers in mentoring and research infrastructure.
Aim 3. Provide training of scientific skills and career development for student/trainees.
Aim 4. Provide opportunities for concurrent parallel programs/organizations that enhance communication and sharing of best practices.
The Congressionally mandated Institutional Development Award (IDEA) Program builds biomedical research capacity in the 23 IDEA eligible states and Puerto Rico, which have historically low levels of NIH funding. Through its various funding mechanisms, the program supports all facets of competitive biomedical research including but not limited to basic, clinical, behavioral, and translational research. In addition, it supports faculty development and infrastructure improvements.
These mechanisms are designed to strengthen an institution's ability to support biomedical research, enhance the competitiveness of investigators in securing nationally research funding, and enable clinical and translational research to meet the needs of medically underserved communities.
There are five main components of the IDEA Program: (I) Centers of Biomedical Research Excellence (COBRE), (II) the IDEA Networks of Biomedical Research Excellence (INBRE), (III) the IDEA Infrastructure for Clinical and Translational Research (IDEA-CTR), (IV) STTR Regional Technology Transfer Accelerator Hubs for IDEA States, and the (V) IDEA Co-Funding. Each is designed to enhance research infrastructure and faculty development in IDEA-eligible states. Each program has common needs and similar challenges.
The current proposal will enhance the success of these programs by providing a unique forum for the exchange of ideas and solutions to common problems, as well as foster collaborations among IDEA institutions. In partnership with the IDEA community, NIGMS IDEA officials, and Louisiana State University serving as the meeting contractor, this renewal application requests support for multi-year conferences in response to NIH support for conferences and scientific meetings (Parent R13/U13) (PA-20-207).
The goal is to organize and convene the next three National Idea Symposium of Biomedical Research Excellence (NISBRE) conferences planned for 2022, 2024, and 2026. These highly impactful biennial symposia provide an important platform to showcase the scientific achievements of the 252 IDEA program-funded centers. In addition, the NISBRE conferences provide unique technical workshops, working groups, and forums to promote best practices across IDEA states that enhance mentoring of junior basic and translational scientists and their career development. It will significantly enhance the collaborative interactions among IDEA community partners, scientists, and positively impact future funding opportunities.
The specific aims are:
Aim 1. Plan and organize a biennial scientific symposium to showcase research and enhance communications among all IDEA programs.
Aim 2. Provide educational workshops to expand technological repertoire and career skills that improve competitiveness. This aim will seek to promote the development of best practices and publish guidelines based on the extensive expertise of IDEA researchers in mentoring and research infrastructure.
Aim 3. Provide training of scientific skills and career development for student/trainees.
Aim 4. Provide opportunities for concurrent parallel programs/organizations that enhance communication and sharing of best practices.
Awardee
Funding Goals
THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Baton Rouge,
Louisiana
708030001
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 336% from $193,243 to $841,871.
Louisiana State University was awarded
National IDeA Symposium of Biomedical Research Excellence - NISBRE
Cooperative Agreement U13GM143856
worth $841,871
from the National Institute of General Medical Sciences in April 2022 with work to be completed primarily in Baton Rouge Louisiana United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.859 Biomedical Research and Research Training.
The Cooperative Agreement was awarded through grant opportunity Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).
Status
(Ongoing)
Last Modified 7/25/25
Period of Performance
4/1/22
Start Date
3/31/27
End Date
Funding Split
$841.9K
Federal Obligation
$0.0
Non-Federal Obligation
$841.9K
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U13GM143856
Transaction History
Modifications to U13GM143856
Additional Detail
Award ID FAIN
U13GM143856
SAI Number
U13GM143856-4002387929
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NS00 NIH National Institute of General Medical Sciences
Funding Office
75NS00 NIH National Institute of General Medical Sciences
Awardee UEI
ECQEYCHRNKJ4
Awardee CAGE
4L859
Performance District
LA-06
Senators
Bill Cassidy
John Kennedy
John Kennedy
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute of General Medical Sciences, National Institutes of Health, Health and Human Services (075-0851) | Health research and training | Grants, subsidies, and contributions (41.0) | $258,529 | 100% |
Modified: 7/25/25